TSCM-Allogeneic Anti-BCMA CAR-T Shows Promise in Myeloma
In a groundbreaking advance that could redefine treatment paradigms for relapsed and refractory multiple myeloma, researchers have developed a novel ...
In a groundbreaking advance that could redefine treatment paradigms for relapsed and refractory multiple myeloma, researchers have developed a novel ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine